4-胺基吡啶於改善具有脫髓鞘及其他神經系統狀況之患者的神經認知及/或神經精神缺陷之用途
- 专利权人:
- ACORDA THERAPEUTICS; INC.
- 发明人:
- WESSEL, THOMAS C.,威索 汤马士Ｃ,威索 湯馬士Ｃ,BLIGHT, ANDREW,布莱特 安德鲁,布萊特 安德魯,威索 汤马士C,威索 湯馬士C,布莱特 安德鲁,布萊特 安德魯
- 申请号：
- TW099126795
- 公开号：
- TWI549678B
- 申请日:
- 2010.08.11
- 申请国别(地区):
- TW
- 年份:
- 2016
- 代理人:
- 摘要：
- Disclosed herein are methods and compositions related to use of aminopyridines, such as fampridine, to improve the neuro-cognitive or neuro-psychiatric impairments of patients with a demyelinating condition, such as MS； traumatic brain injury； cerebral palsy； or post-radiation encephalopathy.本發明係關於一種方法及組合物，其係關於胺基吡啶(諸如氨吡啶(fampridine))於改善具有脫髓鞘狀況(諸如MS)；創傷性腦損傷；大腦性麻痺；或輻射後腦病變之患者的神經認知或神經精神缺陷之用途。
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH DEMYELINATING AND OTHER NERVOUS SYSTEM CONDITIONS
- "METHOD FOR DELAYING CLINICALLY DEFENTIVE MULTIPLE SCIENCE ACCESS IN A PATIENT RISK OF CLINICALLY DEVELOPING MULTIPLE DECLINING PROCEDURE IN THE CURRENT DEVELOPMENT OF THE PROGRESS OF MONITOR RISK DEVELOPING CLINICALLY DEFINING MULTIPLE SCLEROSIS, A METHOD TO REDUCE DEFINITIVE MULTIPLE SCLEROSIS SYMPTOMS IN A PATIENT SUGGESTIVE MULTIPLE SCLEROSIS, METHOD TO DELAY THE PROGRESS FOR CLINICALLY DEFINING MULTIPLE SCLEROSIS IN A PATIENT WHO HAS A FIRST CLINICAL EVENT SUGGESTED BY THE MUSCLES
- CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
- Cladribine regimen for treating multiple sclerosis
- CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
